Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome

Project Information

CureCN

Grant agreement ID: 755225

DOI 10.3030/755225

Project closed

EC signature date 5 December 2017

Start date 1 January 2018

End date 30 June 2023

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being
• Treating and managing disease

Total cost € 6 249 103,75

EU contribution € 6 249 103,75

Coordinated by

ASSOCIATION GENETHON
France

• Gene therapy trials point to cure for rare liver disease
  EN